NASDAQ: HCAT · Technology · 5 alerts · CIK 1636422
Share price
$1.38Close, Nov 16
Market cap
$105M
Shares outstanding
76.16MLatest SEC cover page
Sector
Technology
Industry
Services-Computer Programming, Data Processing, Etc.SIC 7370
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Health Catalyst, Inc. filings on SEC EDGAR ↗
Health Catalyst General Counsel Benjamin Landry Sells $141K of Stock
Benjamin Landry, General Counsel, sold 99,478 shares of Health Catalyst, Inc. at $1.39 to $1.43 a share (average $1.42) in 2 transactions, worth $141K in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 251,894 (-10.5%).
Health Catalyst, Inc. reported 76,155,467 shares of common stock outstanding as of November 2, 2026. The company is currently focused on migrating clients from its DOS platform to the new Health Catalyst Ignite platform, while managing risks related to macroeconomic volatility and the recent divestiture of Vitalware.
Health Catalyst reported Q3 2026 financial results, beating the high end of its revenue and Adjusted EBITDA guidance despite a 26% year-over-year revenue decline following the divestiture of its Vitalware business. The company reported GAAP net income of $40.5 million, primarily driven by a $65.9 million gain on the sale of Vitalware, and reaffirmed its full-year 2026 outlook.
Term
3 months
“We delivered a third quarter above the high end of our revenue and Adjusted EBITDA guidance, and we are reaffirming our full-year outlook. Our immediate priority is to strengthen the foundation of the business, with a focus on retaining the clients we serve and developing a path to generating durable, profitable revenue.”
Simeon Kohl, President and Chief Executive Officer